Verily raises $300M, converts to corporation as Alphabet loses controlling stake
What's the deal? VerilyDealroom has a profile for this one. Try Dealroom →, the precision health company that graduated from Google X a decade ago, has raised $300M in a funding round led by Series X CapitalDealroom has a profile for this one. Try Dealroom →. AlphabetDealroom has a profile for this one. Try Dealroom →, UCHealthDealroom has a profile for this one. Try Dealroom →, and the University of Colorado Anschutz also participated. As part of the deal, Verily has converted from an LLC to a corporation, now officially called Verily Health Inc.
Alphabet remains a significant minority investor but no longer holds a controlling stake — a major shift for one of its earliest "Other Bets."
Why now? Verily is betting big on AI-powered precision health and needs capital and corporate independence to scale. The company has been building commercial momentum through recent partnerships with Samsung, Salesforce, and UCHealth, integrating its Pre platform into clinical research and care workflows.
"From research to care, our customers need solutions that bring the best of clinical and scientific rigor together with AI to deliver the next generation of healthcare," chief executive officer Stephen Gillett said.
What could go wrong? Losing Alphabet's controlling stake means Verily gains autonomy but also loses the implicit safety net of its parent company. The health AI space is increasingly crowded, and converting ambitious partnerships into sustainable revenue is notoriously hard in healthcare — where regulatory hurdles, data privacy concerns, and slow adoption cycles can stall even well-funded ventures.
The signal: Verily's shift from Alphabet-controlled LLC to independently capitalised corporation — now at the late growth stage, according to Dealroom — marks a maturation moment for one of the most closely watched health-tech moonshots. The involvement of UCHealth as both a commercial partner and an investor suggests that health systems are increasingly willing to put capital behind the AI platforms they adopt, blurring the line between customer and backer in ways that could accelerate enterprise sales cycles across the sector.
Read more: mpo-mag.com
